|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Merck_KGaA's_biosimilars_business
gptkb:Mylan_N.V.
gptkb:Upjohn_division_of_Pfizer
2020
|
|
gptkbp:CEO
|
gptkb:Heather_Bresch
|
|
gptkbp:employees
|
over 35,000
|
|
gptkbp:focus
|
affordable healthcare
|
|
gptkbp:founded
|
1961
|
|
gptkbp:founder
|
Milton_P._H._H._Mylan
|
|
gptkbp:headquarters
|
gptkb:Canonsburg,_Pennsylvania
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mylan
|
|
gptkbp:market
|
generic and specialty medications
|
|
gptkbp:operates_in
|
over 165 countries
|
|
gptkbp:partnerships
|
gptkb:Eli_Lilly
gptkb:GSK
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Zymeworks
gptkb:Acorda_Therapeutics
gptkb:Alder_BioPharmaceuticals
gptkb:Bayer_AG
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Pfizer_Inc.
gptkb:Teva_Pharmaceutical_Industries
gptkb:Merck_&_Co.
gptkb:Roche
gptkb:Amgen
gptkb:Gilead_Sciences
gptkb:Sandoz
gptkb:Hikma_Pharmaceuticals
gptkb:Vertex_Pharmaceuticals
gptkb:MediGene_AG
gptkb:Sierra_Oncology
Novartis
Sanofi
AbbVie
Celgene
Biosimilars
NantKwest.
|
|
gptkbp:products
|
generic drugs
specialty pharmaceuticals
|
|
gptkbp:revenue
|
$11.5 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
MYL
|
|
gptkbp:subsidiary
|
gptkb:Mylan_India
gptkb:Mylan_Pharmaceuticals_Inc.
gptkb:Mylan_N.V.
|